Glioblastoma is a deadly disease, but researchers at the MUHC have uncovered a therapy that may change the prognosis for patients.

It’s a diagnosis that can devastate a patient – glioblastoma multiforme. It is an extremely aggressive brain tumor that is resistant to treatment. Radiotherapy, chemotherapy, even extensive attempts to remove the tumor surgically cannot force the cancer into remission, leaving physicians with few options. Despite the emergence of intensive treatment strategies, the median survival of patients with glioblastoma is 16 months and only 3-5% of patients survive longer than 3 years. 

We need your help to make this unprecedented therapy available to all.